CLHLF: AI 评分 49/100 — AI 分析 (4月 2026)

COLTENE Holding AG is a global developer, manufacturer, and seller of dental supplies and equipment. The company offers a comprehensive range of products for dental professionals, including restoratives, endodontics, prosthetics, and infection control solutions.

Key Facts: AI Score: 49/100 Sector: Healthcare

公司概况

概要：

COLTENE Holding AG, a Swiss-based company, develops and markets a comprehensive portfolio of dental supplies and equipment, including restoratives, endodontics, and prosthetics. With a global presence and a focus on innovation, COLTENE serves dentists and dental laboratories across Europe, the Americas, and Asia/Oceania, holding a significant position in the dental consumables market.

CLHLF是做什么的？

COLTENE Holding AG, originally incorporated as Medisize Holding AG in 2005 and renamed in 2008, is a global company dedicated to the development, manufacturing, and distribution of dental supplies and equipment. Headquartered in Altstätten, Switzerland, COLTENE serves dentists and dental laboratories worldwide. The company's product portfolio includes a wide array of dental solutions, such as restoration products like composites and CAD/CAM materials, endodontic products including root canal instruments and obturation materials, prosthetics like impression materials, and treatment auxiliaries such as infection control products. COLTENE's evolution has been marked by a focus on innovation and expansion into new markets. The company has strategically developed its product lines to meet the evolving needs of dental professionals, emphasizing high-quality materials and user-friendly designs. COLTENE's global reach extends across Europe, the Middle East, Africa, North America, Latin America, and Asia/Oceania, supported by a network of distributors and direct sales teams. With a workforce of 1,176 employees, COLTENE is committed to providing comprehensive solutions that enhance the efficiency and effectiveness of dental practices.

CLHLF的投资论点是什么？

COLTENE Holding AG presents a notable market position within the dental supplies market. The company's diversified product portfolio, global reach, and focus on innovation provide a solid foundation for growth. With a P/E ratio of 18.85 and a dividend yield of 5.30%, COLTENE offers a balance of value and income potential. Ongoing catalysts include increasing demand for advanced dental materials and equipment, particularly in emerging markets. Potential risks include competition from larger players in the dental industry and fluctuations in currency exchange rates. The company's ability to maintain its profit margin of 6.2% and gross margin of 46.2% will be crucial for sustained profitability.

CLHLF在哪个行业运营？

The medical instruments and supplies industry is characterized by continuous innovation and increasing demand for advanced dental solutions. The global dental consumables market is expected to grow, driven by factors such as an aging population, rising disposable incomes, and increasing awareness of oral hygiene. COLTENE Holding AG operates in a competitive landscape that includes established players and emerging companies. Key competitors include AVCTF (Envista Holdings Corporation), BOVNF (Dentsply Sirona), and JNDOF (Straumann). COLTENE differentiates itself through its comprehensive product portfolio, global reach, and focus on high-quality materials.

Medical - Instruments & Supplies

Healthcare

CLHLF有哪些增长机遇？

Expansion in Emerging Markets: COLTENE has the opportunity to expand its presence in emerging markets, particularly in Asia and Latin America. These regions are experiencing rapid growth in dental care demand due to increasing disposable incomes and rising awareness of oral hygiene. By establishing strategic partnerships and tailoring its product offerings to local needs, COLTENE can capture a significant share of these growing markets. This expansion could contribute to revenue growth of 10-15% over the next 3-5 years.
Product Innovation and Development: COLTENE can drive growth through continuous product innovation and development. By investing in research and development, the company can introduce new and improved dental materials and equipment that meet the evolving needs of dental professionals. This includes developing advanced composites, CAD/CAM solutions, and endodontic products. Successful product innovation can lead to increased market share and higher profit margins. Expect to see new products contributing 5-8% to revenue growth annually.
Strategic Acquisitions: COLTENE can pursue strategic acquisitions to expand its product portfolio and geographic reach. By acquiring complementary businesses, the company can gain access to new technologies, markets, and customer segments. This can accelerate growth and enhance its competitive position. Potential acquisition targets include companies specializing in niche dental products or those with a strong presence in specific geographic regions. Acquisitions could add 8-12% to overall revenue within 2-4 years.
Digital Dentistry Solutions: COLTENE can capitalize on the growing trend of digital dentistry by developing and offering comprehensive digital solutions. This includes CAD/CAM systems, intraoral scanners, and 3D printers. By providing integrated digital workflows, COLTENE can help dental professionals improve efficiency, accuracy, and patient outcomes. The digital dentistry market is expected to grow significantly in the coming years, presenting a substantial growth opportunity for COLTENE. Expect digital solutions to contribute 10-15% to revenue within 5 years.
Enhanced Customer Training and Support: COLTENE can strengthen its customer relationships and drive sales by providing enhanced training and support to dental professionals. This includes offering hands-on training courses, online resources, and technical support. By helping customers effectively use its products, COLTENE can increase customer satisfaction and loyalty. This can lead to repeat business and positive word-of-mouth referrals. Improved customer support could increase sales by 5-7% annually.

Market capitalization of $0.37 billion, reflecting the company's established position in the dental supplies market.
P/E ratio of 18.85, suggesting a reasonable valuation compared to its earnings.
Dividend yield of 5.30%, offering an attractive income stream for investors.
Gross margin of 46.2%, indicating efficient cost management in its manufacturing and distribution processes.
Beta of 0.80, suggesting lower volatility compared to the overall market.

CLHLF提供哪些产品和服务？

Develops and manufactures dental restoration products, including composites and bonding agents.
Offers a range of endodontic solutions, such as root canal files and obturation materials.
Provides prosthetics products, including impression materials and bite registration systems.
Manufactures treatment auxiliaries like dental dams, aspirator tips, and cotton products.
Offers infection control products, including ultrasonic cleaning units and protective barriers.
Supplies rotary instruments such as burs and polishers for dental procedures.
Provides laboratory products, including gingiva masks and model-making materials.

CLHLF如何赚钱？

Develops and manufactures a wide range of dental products and equipment.
Sells products directly to dental professionals and laboratories, as well as through distributors.
Generates revenue through the sale of consumables, tools, and equipment.
Invests in research and development to innovate and expand its product portfolio.

Dentists in private practices.
Dental laboratories.
Dental clinics and hospitals.
Dental distributors and retailers.

Established brand reputation for high-quality dental products.
Comprehensive product portfolio covering various dental specialties.
Global distribution network providing access to diverse markets.
Strong relationships with dental professionals and laboratories.
Intellectual property protection for key products and technologies.

什么因素可能推动CLHLF股价上涨？

Ongoing: Increasing demand for dental consumables in emerging markets.
Ongoing: Product innovation and development of advanced dental solutions.
Ongoing: Strategic acquisitions to expand product portfolio and geographic reach.
Upcoming: Potential regulatory approvals for new dental products in key markets.
Ongoing: Growth in digital dentistry solutions and adoption by dental professionals.

CLHLF的主要风险是什么？

Potential: Intense competition from established and emerging players in the dental industry.
Potential: Changes in dental regulations and reimbursement policies affecting product sales.
Potential: Economic downturns impacting dental care spending and demand for products.
Ongoing: Exposure to currency exchange rate fluctuations affecting financial performance.
Potential: Product recalls or liability claims impacting brand reputation and financial results.

CLHLF的核心优势是什么？

Comprehensive product portfolio covering various dental specialties.
Global distribution network providing access to diverse markets.
Established brand reputation for high-quality dental products.
Strong relationships with dental professionals and laboratories.

CLHLF的劣势是什么？

Exposure to currency exchange rate fluctuations.
Dependence on distributors in certain markets.
Limited brand recognition compared to larger competitors.
Higher cost structure compared to some competitors.

CLHLF有哪些机遇？

Expansion in emerging markets with growing dental care demand.
Development of innovative digital dentistry solutions.
Strategic acquisitions to expand product portfolio and geographic reach.
Increased focus on customer training and support.

CLHLF面临哪些威胁？

Intense competition from established and emerging players.
Changes in dental regulations and reimbursement policies.
Economic downturns affecting dental care spending.
Product recalls or liability claims.

CLHLF的竞争对手是谁？

Envista Holdings Corporation — Offers a broad range of dental products and equipment. — (AVCTF)
Dentsply Sirona — A major player in dental equipment and consumables. — (BOVNF)
Straumann — Specializes in dental implants and related products. — (JNDOF)
Kuraray — Known for its dental adhesives and composites. — (KHTRF)
Nobel Biocare — Focuses on implant-based dental restorations. — (LBLTF)

Key Metrics

MoonshotScore: 49/100

Company Profile

CEO: Dominik Arnold
Headquarters: Altstätten, CH
Employees: 1,176
Founded: 2015

AI Insight

AI analysis pending for CLHLF

OTC Tier: OTC Other
Disclosure Status: Unknown

常见问题

What does COLTENE Holding AG do?

COLTENE Holding AG develops, manufactures, and sells a comprehensive range of dental supplies and equipment for dentists and dental laboratories worldwide. Its product portfolio includes restoratives, endodontics, prosthetics, treatment auxiliaries, infection control products, and rotary instruments. The company serves customers in Europe, the Middle East, Africa, North America, Latin America, and Asia/Oceania, providing solutions that enhance the efficiency and effectiveness of dental practices.

What do analysts say about CLHLF stock?

AI analysis is currently pending for CLHLF. Generally, analysts consider factors such as market trends, competitive landscape, and company-specific developments when evaluating a stock. Key valuation metrics, such as the P/E ratio and dividend yield, are also considered. Growth considerations include the company's ability to expand its product portfolio, penetrate new markets, and maintain profitability. However, without specific analyst reports, a detailed assessment is not possible.

What are the main risks for CLHLF?

The main risks for COLTENE Holding AG include intense competition from established and emerging players in the dental industry. The company is also exposed to currency exchange rate fluctuations, which can affect its financial performance. Changes in dental regulations and reimbursement policies could impact product sales. Economic downturns may affect dental care spending and demand for products. Product recalls or liability claims could also pose a risk to the company's brand reputation and financial results.